Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lawrence Baruch

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Cardiology|August 13, 2022
Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart FailurePersio David Lopez, Kirtipal Bhatia, Chandrashekar Bohra, et al.
Journal of Clinical Lipidology|December 3, 2010
Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?Lawrence Baruch, Sanjay Agarwal, Bhanu Gupta, et al.
Stroke|August 4, 2007
Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?Lawrence Baruch, Brian F Gage, Jay Horrow, et al.
The American Journal of Cardiology|February 8, 2005
Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)Silja K Majahalme, Lawrence Baruch, Nora Aknay, et al.
Journal of the American College of Cardiology|February 13, 2007
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMESHans Persson, Eva Lonn, Magnus Edner, et al.
American Heart Journal|January 6, 2005
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)Lawrence Baruch, Robert D Glazer, Nora Aknay, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
The American Journal of Cardiology|August 13, 2022
Benefits of Adding Glucagon-Like Peptide 1 Receptor Agonists to Sodium-Glucose Co-Transporter 2 Inhibitors in Diabetic Patients With Atherosclerotic Disease and Heart FailurePersio David Lopez, Kirtipal Bhatia, Chandrashekar Bohra, et al.
Journal of Clinical Lipidology|December 3, 2010
Is directly measured low-density lipoprotein clinically equivalent to calculated low-density lipoprotein?Lawrence Baruch, Sanjay Agarwal, Bhanu Gupta, et al.
Stroke|August 4, 2007
Can patients at elevated risk of stroke treated with anticoagulants be further risk stratified?Lawrence Baruch, Brian F Gage, Jay Horrow, et al.
The American Journal of Cardiology|February 8, 2005
Comparison of treatment benefit and outcome in women versus men with chronic heart failure (from the Valsartan Heart Failure Trial)Silja K Majahalme, Lawrence Baruch, Nora Aknay, et al.
Journal of the American College of Cardiology|February 13, 2007
Diastolic dysfunction in heart failure with preserved systolic function: need for objective evidence:results from the CHARM Echocardiographic Substudy-CHARMESHans Persson, Eva Lonn, Magnus Edner, et al.
American Heart Journal|January 6, 2005
Morbidity, mortality, physiologic and functional parameters in elderly and non-elderly patients in the Valsartan Heart Failure Trial (Val-HeFT)Lawrence Baruch, Robert D Glazer, Nora Aknay, et al.
Pageof 2